|
|
Article: ALLHAT study recommends diuretics; Dyrenium reduces side effects.
- Article from:
- Biotech Week
- Article date:
- January 22, 2003
CopyrightCOPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2003 JAN 22 - (NewsRx.com & NewsRx.net) -- WellSpring Pharmaceutical Corporation commented on findings of the ALLHAT hypertension study, the National Institutes of Health's study on antihypertensive and lipid-lowering treatments for heart attacks.
The study concluded that certain diuretic drugs are more effective than newer, more expensive drugs in treating high blood pressure and preventing some forms of heart disease.
Officials with WellSpring remind, however, that diuretics, if used alone for extended periods, can result in electrolyte imbalances and the loss of vital minerals such as potassium.
Dyrenium (Triamterene), WellSpring's leading ...